Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Symptoms to Diagnosis

Rapid cognitive decline and myoclonus in a 52-year-old woman

William Gravley, MS, Caleb Murphy, MD, MBA, Chia-Dan Kang, MD and Badrunnisa Hanif, MD
Cleveland Clinic Journal of Medicine October 2021, 88 (10) 572-583; DOI: https://doi.org/10.3949/ccjm.88a.20004
William Gravley
Kirk Kerkorian School of Medicine, University of Nevada-Las Vegas, Las Vegas, NV
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Caleb Murphy
Kirk Kerkorian School of Medicine, University of Nevada-Las Vegas, Las Vegas, NV
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chia-Dan Kang
Kirk Kerkorian School of Medicine, University of Nevada-Las Vegas, Las Vegas, NV
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Badrunnisa Hanif
Kirk Kerkorian School of Medicine, University of Nevada-Las Vegas, Las Vegas, NV
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Diffusion-weighted magnetic resonance imaging at admission shows cortical bifrontal (red arrow) and parietal (green arrow) diffusion (cortical ribboning), with greater intensity on the left. No thalamic hyperintensity was seen. Note that the quality of this image was affected by patient movement during the procedure, in spite of attempts to sedate her.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Electroencephalography showed continuous triphasic waves (red boxes) and diffuse cortical slowing. Diffuse slowing is seen throughout the recording, as the background frequency consists mostly of theta waves (frequency 4–7 Hz) despite provoking maneuvers and the patient not being on sedating medications.

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    Immunohistochemical staining shows fine prion protein deposits in the molecular layer, coarser deposits in the granular layer, and plaques in both layers of the cerebellum (magnification × 600). Fine deposits in the upper portion (molecular layer) of the image appear as numerous dark deposits. The red arrow points to coarse deposits in the granular layer, and the black arrow points to plaque.

    From Kovács GG, Head MW, Hegyi I, et al. Immunohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes. Brain Pathol 2002; 12(1):1–11. doi:10.1111/j.1750-3639.2002.tb00417.x. Copyright John Wiley and Sons, Inc. Reprinted with permission.

Tables

  • Figures
    • View popup
    TABLE 1

    Diagnostic tests for Creutzfeldt-Jakob disease: Sensitivity and specificity

    TestingSensitivitySpecificityDiagnostic criteriaNotes
    Magnetic resonance imaging
    DWI or FLAIR3083%83%At least 2 cortical regions affected (parietal–temporal–occipital) or both putamen and nucleus caudatum affectedRetrospective evaluation of pathology-proven CJD
    DWI and FLAIR3191%95%2005 UCSF MRI criteria for CJD31Retrospective evaluation of clinically diagnosed prion disease, majority spontaneous CJD (83%); excellent interreader reliability (kappa 0.96)
    DWI and FLAIR3296%93%2005 UCSF MRI criteria for CJD31Retrospective evaluation of clinically diagnosed prion disease, majority spontaneous CJD (79%)
    DWI3392%94%High-intensity lesions in the striatum (caudate or putamen, or both), lesions in the thalamus including the pulvinar, and/or lesions along the cortical ribbon (cerebral or cerebellar)Retrospective evaluation of clinically diagnosed prion disease, majority spontaneous CJD (78%)
    Electroencephalography32
    64%91%1996 Steinhoff criteria27Retrospective evaluation of pathology-proven CJD
    Cerebrospinal fluid studies34
    14-3-3 protein83%63%Positive testRetrospective analysis of 111 neuropathologically confirmed sCJD cases
    Total tau protein91% 46%Positive test
    RT-QuIC92% 99%Positive test
    • CJD = Creutzfeldt-Jakob disease; DWI = diffusion-weighted imaging; FLAIR = fluid-attenuated inversion recovery; RT-QulC = real-time quaking-induced conversion; sCJD = sporadic Creutzfeldt-Jakob disease; UCSF = University of California, San Francisco

    • View popup
    TABLE 2

    Criteria for probable diagnosis of sporadic CJD

    1. Neuropsychiatric disorder plus positive RT-QuIC in cerebrospinal fluid or other tissues

      OR

    2. All 3 of the following subcriteria:

      1. Rapidly progressive dementia and at least 2 of these 4 clinical features:

        • Myoclonus

        • Visual or cerebellar disturbances

        • Pyramidal or extrapyramidal dysfunction

        • Akinetic mutism

      2. A positive result on at least 1 of the following laboratory tests:

        • Typical electroencephalogram (periodic sharp-wave complexes) during an illness of any duration

        • Positive 14-3-3 protein cerebrospinal fluid assay in patient with a disease duration of less than 2 years

        • High signal in caudate and/or putamen on MRI, or in at least 2 cortical regions (temporal, parietal, occipital) on DWI or FLAIR

      3. No routine investigation indicates an alternative diagnosis

    • CJD = Creutzfeldt-Jakob disease DWI = diffusion-weighted imaging; FLAIR = fluid-attenuated inversion recovery; MRI = magnetic resonance imaging; RT-QulC = real-time quaking-induced conversion.

      From US Centers for Disease Control and Prevention, reference 41.

PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 88 (10)
Cleveland Clinic Journal of Medicine
Vol. 88, Issue 10
1 Oct 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Rapid cognitive decline and myoclonus in a 52-year-old woman
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rapid cognitive decline and myoclonus in a 52-year-old woman
William Gravley, Caleb Murphy, Chia-Dan Kang, Badrunnisa Hanif
Cleveland Clinic Journal of Medicine Oct 2021, 88 (10) 572-583; DOI: 10.3949/ccjm.88a.20004

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Rapid cognitive decline and myoclonus in a 52-year-old woman
William Gravley, Caleb Murphy, Chia-Dan Kang, Badrunnisa Hanif
Cleveland Clinic Journal of Medicine Oct 2021, 88 (10) 572-583; DOI: 10.3949/ccjm.88a.20004
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • DIFFERENTIAL DIAGNOSIS: DISEASES, CONDITIONS TO RULE OUT
    • CASE CONTINUED
    • AUTOANTIBODY ENCEPHALITIS: WHAT TO LOOK FOR
    • CASE CONTINUED
    • NEXT STEP: ADDITIONAL IMAGING
    • CASE CONTINUED
    • WHY TEST FOR PRION DISEASE?
    • CASE CONTINUED
    • EPIDEMIOLOGY OF PRION DISEASES
    • PATHOLOGY DRIVES PRECAUTIONS
    • TREATMENT AND PROGNOSIS
    • TAKE-HOME MESSAGES
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Thyroid obstacle course: Many challenges from a single gland
  • Shortness of breath in a 52-year-old man with HIV and severe mitral regurgitation
  • A 74-year-old woman with purple toes
Show more Symptoms to Diagnosis

Similar Articles

Subjects

  • Drug Therapy
  • Emergency Medicine
  • Genetics
  • Imaging
  • Infectious Diseases
  • Mental Health
  • Neurology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire